ARCHIVES

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

June 19, 1992

NCCAM Awards To Establish Two Cancer Research Centers.

October 13, 2000

ACS Picks Up Study Of tobacco Industry Influence On Voting By State Legislators

May 3, 1996